Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
公司代碼PODD
公司名稱Insulet Corp
上市日期May 15, 2007
CEOMcevoy (Ashley)
員工數量3900
證券類型Ordinary Share
年結日May 15
公司地址100 Nagog Park
城市ACTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01720-3440
電話19786007000
網址https://www.omnipod.com
公司代碼PODD
上市日期May 15, 2007
CEOMcevoy (Ashley)